Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2018

Open Access 01-12-2018 | Commentary

Reflection paper on copyright, patient-reported outcome instruments and their translations

Authors: Caroline Anfray, Benjamin Arnold, Mona Martin, Sonya Eremenco, Donald L. Patrick, Katrin Conway, Catherine Acquadro, on behalf of the ISOQOL Translation and Cultural Special Interest Group (TCA-SIG)

Published in: Health and Quality of Life Outcomes | Issue 1/2018

Login to get access

Abstract

With the growth of patient-reported outcome (PRO) measurement, questions arise regarding how copyright protection applies to PRO instruments in general and to their translations in particular. The main objectives of this reflection paper are: 1) to help authors of PRO instruments understand basic rules of intellectual property and copyright that protect the integrity of their instruments and derivatives; and 2) to provide recommendations to authors and users of PRO instruments to prevent misuse or abuse.
National laws on intellectual property (IP) and the international Berne Convention fully apply to PRO instruments since they are creations of the mind. Therefore, the copyright holder / owner / claimant of a PRO instrument, i.e., the person or legal entity who owns the copyright of the instrument, is granted exclusive rights that are divided into two main categories: moral and economic rights. Moral rights are: 1) the right of attribution (or right of paternity), i.e., the right to claim authorship of the work, 2) the right against false attribution, and 3) the right of integrity, i.e., the right to object to any mutilation, deformation or modification of the work. Economic rights represent the exclusive rights of the author to make or authorize reproduction, development of derivative works, distribution and communication to the public. In other words, the PRO instrument’s copyright holder controls access (distribution, reproduction), and authorizes all derivative works, i.e., adaptations (e.g., electronic formats), modifications (e.g., shorter versions), and translations. Hence, the access to and use of an original PRO instrument and its derivatives in any kind of research should always be associated with the identification of its copyright holder. However, in some cases, this identification may be challenging, in particular when copyright ownership is not clearly defined. To prevent ownership conflicts as well as misuse or abuse of PRO instruments, the ISOQOL Translation and Cultural Adaptation Special Interest Group (TCA-SIG) provides recommendations to authors of PRO instruments and their users. In particular, the TCA-SIG recommends that the ownership of PRO instruments and their derivatives should be defined from the beginning (i.e., from the development of the instrument) and along the life cycle of the instrument between all parties involved. These recommendations apply not only to PRO instruments but also to all the other clinical outcome assessments (COAs), since they are also creations of the mind.
Literature
6.
go back to reference Anfray C, Emery MP. Use of PRO instruments: licensing and copyright issues. [abstract]. Qual Life Res. 2006;15(suppl 1):A-112. Anfray C, Emery MP. Use of PRO instruments: licensing and copyright issues. [abstract]. Qual Life Res. 2006;15(suppl 1):A-112.
7.
go back to reference Anfray C, Emery MP. Access and use of Patient-Reported Outcomes (PRO) instruments in international studies: authorship and copyright issues. [abstract]. Qual Life Res. 2007;16(suppl):A-21. Anfray C, Emery MP. Access and use of Patient-Reported Outcomes (PRO) instruments in international studies: authorship and copyright issues. [abstract]. Qual Life Res. 2007;16(suppl):A-21.
8.
go back to reference Bilon JL, Vivant M, Navarro JL. Code de la Propriété Intellectuelle. Paris: Edition Litec; 2011. Bilon JL, Vivant M, Navarro JL. Code de la Propriété Intellectuelle. Paris: Edition Litec; 2011.
10.
go back to reference Anfray C. Patient-reported outcomes instruments: bridging the gap between international copyright laws and common practice for developers and users--a case example. Qual Life Res. 2009;18(10):1281–3.CrossRefPubMed Anfray C. Patient-reported outcomes instruments: bridging the gap between international copyright laws and common practice for developers and users--a case example. Qual Life Res. 2009;18(10):1281–3.CrossRefPubMed
11.
go back to reference Grammatopoulou E, Skordilis E, Koutsouki D, Baltopoulos G. An 18-item standardised asthma quality of life questionnaire—AQLQ(S). Qual Life Res. 2008;17(2):323–32.CrossRefPubMed Grammatopoulou E, Skordilis E, Koutsouki D, Baltopoulos G. An 18-item standardised asthma quality of life questionnaire—AQLQ(S). Qual Life Res. 2008;17(2):323–32.CrossRefPubMed
12.
go back to reference Juniper EF. Modification, translation and adaptation of questionnaires. Should copyright laws be observed? Qual Life Res. 2009;18(5):531–3.CrossRefPubMed Juniper EF. Modification, translation and adaptation of questionnaires. Should copyright laws be observed? Qual Life Res. 2009;18(5):531–3.CrossRefPubMed
13.
go back to reference Revicki DA, Schwartz CE. Intellectual property rights and good research practice. Qual Life Res. 2009;18(10):1279–80.CrossRefPubMed Revicki DA, Schwartz CE. Intellectual property rights and good research practice. Qual Life Res. 2009;18(10):1279–80.CrossRefPubMed
14.
go back to reference Coons SJ, Kothari S, Monz BU, Burke LB. The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims. Clin Pharmacol Ther. 2011;90(5):743–8.CrossRefPubMed Coons SJ, Kothari S, Monz BU, Burke LB. The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims. Clin Pharmacol Ther. 2011;90(5):743–8.CrossRefPubMed
Metadata
Title
Reflection paper on copyright, patient-reported outcome instruments and their translations
Authors
Caroline Anfray
Benjamin Arnold
Mona Martin
Sonya Eremenco
Donald L. Patrick
Katrin Conway
Catherine Acquadro
on behalf of the ISOQOL Translation and Cultural Special Interest Group (TCA-SIG)
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2018
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-018-1050-4

Other articles of this Issue 1/2018

Health and Quality of Life Outcomes 1/2018 Go to the issue